Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aquestive Therapeutics Inc
(NQ:
AQST
)
1.600
-0.130 (-7.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 15, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,495,448
Open
1.750
Bid (Size)
1.570 (143)
Ask (Size)
1.600 (15)
Prev. Close
1.730
Today's Range
1.570 - 1.768
52wk Range
0.6180 - 6.400
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
Today 3:43 EDT
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.
Via
Benzinga
Aquestive Therapeutics Reveals Favorable Data From Epinephrine Trial For Allergies
June 16, 2022
Via
Benzinga
Performance
YTD
-62.44%
-62.44%
1 Month
+84.01%
+84.01%
3 Month
+28.00%
+28.00%
6 Month
-35.48%
-35.48%
1 Year
-58.12%
-58.12%
More News
Read More
12 Health Care Stocks Moving In Friday's After-Market Session
August 12, 2022
Via
Benzinga
Aquestive Therapeutics: Q2 Earnings Insights
August 02, 2022
Via
Benzinga
Earnings Preview: Aquestive Therapeutics
August 01, 2022
Via
Benzinga
The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK
June 16, 2022
Via
Benzinga
63 Biggest Movers From Yesterday
June 17, 2022
Via
Benzinga
The Daily Biotech Pulse: Pfizer/BioNTech's COVID-19 Booster For Kids, Moderna Starts First African Trial Of mRNA HIV Vaccine, Tonix Extends COVID-19 Antiviral Research Pact
May 18, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
June 03, 2022
Via
Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 02, 2022
Via
Benzinga
Earnings Outlook For Aquestive Therapeutics
May 02, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 29, 2022
Via
Benzinga
Aquestive's AQST-109 Receives Fast Track Tag For Allergic Reactions
March 17, 2022
Via
Benzinga
Looking Into Aquestive Therapeutics's Return On Capital Employed
March 11, 2022
Via
Benzinga
NASDAQ:AQST Shareholder Notice: Investigation over Potential Wrongdoing at Aquestive Therapeutics, Inc.
March 09, 2022
Via
SBWire
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
March 08, 2022
Via
Benzinga
Earnings Scheduled For March 8, 2022
March 08, 2022
Via
Benzinga
A Preview Of Aquestive Therapeutics's Earnings
March 07, 2022
Via
Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
March 06, 2022
Via
Benzinga
Week In Review: Adagene Forms $2.5 Billion, Four-Drug Partnership With Sanofi
March 05, 2022
Via
Talk Markets
Aquestive Highlights Early Data From Allergy Treatment Candidate AQST-109 Study
February 25, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 25, 2022
Via
Benzinga
The Daily Biotech Pulse: Lilly's Jardiance Gets Nod For Heart Failure, Pulmatrix Announces Reverse Split, Reata Awaits FDA Decision
February 25, 2022
Via
Benzinga
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shareholder Notice: Update in Lawsuit
January 19, 2022
Via
SBWire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.